Colonization for the prevention of Clostridium difficile disease in hamsters.

J Infect Dis

Infectious Disease Section, Department of Medicine, Veterans Affairs Chicago Health Care System, Lakeside Division, Chicago, Illinois, USA.

Published: December 2002

Studies suggest that asymptomatic colonization with Clostridium difficile (CD) decreases the risk of CD-associated disease (CDAD) in humans. A hamster model was used to test the efficacy of colonization with 3 nontoxigenic CD strains for preventing CDAD after exposure to toxigenic CD. Groups of 10 hamsters were given 10(6) nontoxigenic CD spores 2 days after receiving a single dose of clindamycin. Five days later, the hamsters were given 100 spores of 1 of 3 toxigenic CD strains previously shown to cause mortality within 48 h. Each nontoxigenic strain prevented disease in 87%-97% of hamsters that were challenged with toxigenic strains. Failure to prevent CDAD was associated with failure of colonization with nontoxigenic CD. Colonization with nontoxigenic CD strains is highly effective in preventing CDAD in hamsters challenged with toxigenic CD strains, which suggests that use of a probiotic strategy for CDAD prevention in humans receiving antibiotics might be beneficial.

Download full-text PDF

Source
http://dx.doi.org/10.1086/345676DOI Listing

Publication Analysis

Top Keywords

colonization nontoxigenic
12
toxigenic strains
12
clostridium difficile
8
nontoxigenic strains
8
preventing cdad
8
hamsters challenged
8
challenged toxigenic
8
colonization
5
hamsters
5
cdad
5

Similar Publications

Clostridioides difficile is the leading cause of healthcare- and antibiotic-associated diarrhea. Surface layer protein A (SlpA), an essential component of the bacterium's outermost layer, contributes to colonization and inflammation. The peroxisome proliferator-activated receptor gamma (PPAR-γ) has been demonstrated to improve intestinal integrity and prevent inflammation in host cells.

View Article and Find Full Text PDF

A quantitative PCR to detect non-toxigenic .

Microbiol Spectr

January 2025

Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA.

species lacking toxin genes (non-toxigenic or NTCD) may confer protection against CDI. However, current diagnostic tests detect either toxin proteins or toxin genes and cannot detect NTCD. This study developed a molecular testing method that uniquely identified NTCD and assessed its prevalence in a clinical cohort.

View Article and Find Full Text PDF
Article Synopsis
  • Clostridioides difficile (C. difficile) is a major cause of healthcare-related diarrhea, with issues like antibiotic resistance and high relapse rates complicating treatment.
  • *Faecal microbiota transplantation is a potential therapy but understanding the key factors for successful colonization resistance is necessary for its broader application.
  • *Experts highlighted the need for a Controlled Human Infection Model (CHIM) to safely study mild to moderate C. difficile infections, which could lead to new treatments and better insights into how the infection works.*
View Article and Find Full Text PDF

Nontoxigenic Bacteroides fragilis: A double-edged sword.

Microbiol Res

September 2024

Department of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Electronic address:

The contribution of commensal microbes to human health and disease is unknown. Bacteroides fragilis (B. fragilis) is an opportunistic pathogen and a common colonizer of the human gut.

View Article and Find Full Text PDF

Unlabelled: infection (CDI) is a major cause of healthcare-associated diarrhea, despite the widespread implementation of contact precautions for patients with CDI. Here, we investigate strain contamination in a hospital setting and the genomic determinants of disease outcomes. Across two wards over 6 months, we selectively cultured from patients ( = 384) and their environments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!